What is Medi-Caps Ltd (MEDICAPS) share price return in the past 10 years?

Medi-Caps Ltd share price has appreciated 3% annually (CAGR) over the past ten years.

What is the share price of Medi-Caps Ltd (MEDICAPS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Medi-Caps Ltd (MEDICAPS) on 17-Apr-2026 16:59:59 at 16:59 is 29.85.

What is the P/E ratio of Medi-Caps?

The latest standalone P/E ratio of Medi-Caps as of 17-Apr-2026 is 42.40.

What is the P/B ratio of Medi-Caps Ltd (MEDICAPS)?

The latest standalone P/B ratio of Medi-Caps Ltd (MEDICAPS) as of 17-Apr-2026 is 0.55.

What is the 52-week high and low of Medi-Caps Ltd (MEDICAPS)?

The 52-week high of Medi-Caps Ltd (MEDICAPS) is Rs. 46.99 and the 52-week low is Rs. 21.00.

Medi-Caps Ltd (MEDICAPS) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Medi-Caps Ltd (MEDICAPS)
Brand: Medi-Caps

Medi-Caps Ltd (MEDICAPS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 523144 NSE: MEDICAPS | Chemicals | Small Cap

Medi-Caps Ltd (MEDICAPS)

BSE: 523144 NSE: MEDICAPS

Key Metrics

Market Cap

₹37 Cr.

P/E Ratio

42.40

Price to Book (P/B)

0.55

Price to Sales (P/S)

14.03

EV/EBITDA

46.70

Return on Capital Employed (ROCE)

0.43%

Current Price

₹29.9

Return on Equity (ROE)

0.83%

Return on Assets (ROA)

0.82%

Operating Profit Margin

-4.9%

Net Profit Margin

22.97%

Gross Profit Margin

18.4%

Book Value per Share

₹54.5

Sales Growth (YoY)

-66.25%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

-102.48%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-85.6%

52-Week Low / High

₹21 / 47

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

51.36%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Medi-Caps Ltd?

Medi-Caps Ltd revenue growth is -66.3% for FY-2025 , which is below its 5 year CAGR of -26% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Medi-Caps Ltd?

Promoters hold 51.36% of the Medi-Caps Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Medi-Caps Ltd vs industry peers?

Medi-Caps Ltd revenue CAGR is -26.01% , compared to the industry median CAGR of 7.7% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Medi-Caps Ltd belong to?

Medi-Caps Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Stock return of Medi-Caps Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 2.8% based on the current price.

DeciZen - make an informed investing decision on Medi-Caps

Based on:

Data

M-Cap below 100cr DeciZen not available

Medi-Caps stock performance

Key Ratios

Is Medi-Caps Ltd an attractive stock to invest in?

1. Is Medi-Caps Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medi-Caps Ltd is a below average quality company.

2. Is Medi-Caps Ltd undervalued or overvalued?

The key valuation ratios of Medi-Caps Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Medi-Caps Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medi-Caps Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	2.7%	2.3%	1.2%	1.1%	-13%	0%	-0.1%	0.4%	7.6%	0.4%	-
Value Creation Index ⓘ	-0.8	-0.8	-0.9	-0.9	-1.9	NA	-1.0	-1.0	-0.5	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	25	22.8	22.4	21.6	10.9	0	0	0.1	7.2	2.4	3
Sales YoY Gr.	-	-9.1%	-1.8%	-3.3%	-49.5%	-100%	NA	NA	7,070%	-66.3%	-
Adj EPS ⓘ	0.9	0.9	0.5	0.5	-6.7	0	-0.1	0.2	3.1	0.5	0.7
YoY Gr.	-	-1.1%	-51.6%	6.7%	-1489.6%	NA	NA	NA	1385.7%	-85.6%	-
BVPS (₹) ⓘ	52.6	53.2	53.7	54.1	48	48.9	49.2	49	53.3	54	54.5
Adj Net Profit ⓘ	1.2	1.2	0.6	0.6	-8.3	0	-0.1	0.3	3.9	0.6	1
Cash Flow from Ops. ⓘ	1.4	2.7	0.9	1.3	-0.9	2.2	-1	-2.6	3.1	1.9	-
Debt/CF from Ops. ⓘ	0	0	0.2	0.1	-0.1	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-22.9%	-26%	NA	-66.3%
Adj EPS ⓘ	-7.9%	NA	NA	-85.6%
BVPSⓘ	0.3%	2.4%	3.2%	1.3%
Share Price	3%	-4.4%	-6.9%	-32.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.8	1.8	0.8	0.9	-13.1	-0.2	0.4	6.1	0.8	1.3
Op. Profit Mgn % ⓘ	6.5	3.5	2	-0	-83.1	0	-289.2	67.6	-4.9	26.5
Net Profit Mgn % ⓘ	4.7	5.1	2.5	2.8	-76.3	0	253.7	54.3	23	32.9
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	215	235	209	223	297	0	21,080	454	1,480	1,054
Cash Conv. Cycle ⓘ	161	166	144	148	191	0	8,062	176	628	1,042

Recent Performance Summary

Sales growth is good in last 4 quarters at 15.00%

Return on Equity has declined versus last 3 years average to 1.30%

Sales growth has been subdued in last 3 years 0.00%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.7	-3.5
TTM Sales (₹ Cr.)	2.7	15.9
BVPS (₹) ⓘ	54.5	92.9
Reserves (₹ Cr.) ⓘ	55	103
P/BV ⓘ	0.55	0.32
PE ⓘ	42.40	0.00

From the Market
52 Week Low / High (₹)	21.00 / 46.99
All Time Low / High (₹)	0.12 / 91.15
Market Cap (₹ Cr.)	37.2
Equity (₹ Cr.)	12.5
Face Value (₹)	10
Industry PE ⓘ	45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Medi-Caps - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	25.04	22.76	22.35	21.62	10.91	0	0	0.10	7.17	2.42
Operating Expenses ⓘ +	23.41	21.99	21.92	21.66	19.98	0	0.56	0.39	2.33	2.53
Manufacturing Costs	5.42	4.63	4.60	4.63	3.26	0	0.01	0.01	0.12	0.03
Material Costs	10.71	9.84	9.60	9.52	9.25	0	0	0	0.01	0
Employee Cost	4.47	4.46	4.57	4.59	5.55	0	0.45	0.23	0.50	0.97
Other Costs ⓘ	2.81	3.06	3.16	2.92	1.92	0	0.10	0.16	1.69	1.53
Operating Profit ⓘ	1.63	0.77	0.44	-0.04	-9.07	0	-0.56	-0.29	4.84	-0.12
Operating Profit Margin (%)	6.5%	3.4%	2.0%	-0.2%	-83.2%	-	-	-289.0%	67.6%	-4.9%
Other Income ⓘ +	0.46	1.13	0.68	1.14	1.12	0	0.61	0.64	0.15	0.56
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.01	0.02	0.02	0.04	0.01	0	0.01	0	0	0
Depreciation ⓘ	0.33	0.37	0.34	0.35	0.36	0	0.09	0.09	0.16	0.16
Profit Before Tax ⓘ	1.74	1.51	0.76	0.71	-8.32	0	-0.06	0.26	4.83	0.29
Tax ⓘ	0.56	0.35	0.20	0.12	0.01	-0.01	0.01	-0	0.94	-0.27
Profit After Tax	1.18	1.16	0.56	0.59	-8.33	0.01	-0.08	0.26	3.89	0.56
PAT Margin (%)	4.7%	5.1%	2.5%	2.7%	-76.3%	-	-	253.7%	54.3%	23.0%
Adjusted EPS (₹)	1.0	0.9	0.5	0.5	-6.7	0.0	-0.1	0.2	3.1	0.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	65.54	66.37	66.92	67.51	59.85	60.97	61.29	61.11	66.49	67.34
Share Capital ⓘ	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47
Reserves ⓘ	53.07	53.90	54.45	55.04	47.38	48.50	48.82	48.64	54.02	54.87
Debt +	0	0	0.17	0.12	0.06	0	0	0	0	0
Long Term Debt	0	0	0.12	0.06	0	0	0	0	0	0
Short Term Debt	0	0	0.05	0.06	0.06	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	1.87	2.24	1.47	3.08	0.42	0.03	0	0	0.01	0.04
Others Liabilities ⓘ	3.60	3.39	3.25	3.07	1.22	1.63	0.52	0.52	1.60	0.64
Total Liabilities ⓘ	71.01	72.01	71.82	73.78	61.55	62.64	61.81	61.63	68.09	68.03
Fixed Assets
Net Fixed Assets ⓘ +	3.64	3.88	3.93	3.91	3.63	3.26	2.78	2.46	2.26	2.10
Gross Block	20.36	20.93	21.33	21.65	21.65	21.13	19.99	16.99	16.95	16.63
Accumulated Depreciation	16.73	17.05	17.39	17.74	18.02	17.88	17.22	14.53	14.69	14.53
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0.08
Investments ⓘ	49.56	50.37	50.89	51.75	52.15	53.31	53.68	51.98	55.11	56.88
Inventories	7.74	7.60	5.76	6.95	0.53	0.05	0	0	0.03	0.03
Trade Receivables	6.61	6.06	6.94	6.25	2.66	2.41	2.24	2.24	4.65	3.66
Cash Equivalents	1.03	1.97	2.04	2.13	0.75	0.73	0.79	0.04	0.05	0.05
Others Assets ⓘ	2.43	2.13	2.25	2.79	1.83	2.89	2.33	4.91	6	5.23
Total Assets ⓘ	71.01	72.01	71.82	73.78	61.55	62.64	61.81	61.63	68.09	68.03

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1.44	2.70	0.86	1.33	-0.92	2.24	-0.95	-2.60	3.09	1.85
PBT ⓘ	1.74	1.51	0.76	0.71	-8.32	-0.12	-0.06	0.26	4.83	0.29
Adjustment ⓘ	0.33	0.37	0.34	0.35	0.94	1.57	0.58	-0.28	1.65	0.46
Changes in Working Capital ⓘ	-0.09	1.15	-0.07	0.37	6.45	0.79	-1.47	-2.57	-2.44	0.85
Tax Paid ⓘ	-0.54	-0.33	-0.18	-0.10	0	0	0	0	-0.95	0.26
Cash Flow From Investing Activity ⓘ +	-1.31	-1.76	-0.96	-1.19	-0.40	-2.19	1.01	1.85	-3.09	-1.85
Capex	-0	-0.61	-0.40	-0.33	0	0.04	0.30	0.15	0.04	-0.07
Net Investments	-1.31	-1.15	-0.56	-0.86	-0.41	-2.23	0.71	1.70	-3.13	-1.78
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0	0	0.17	-0.05	-0.06	-0.06	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0.17	-0.05	-0.06	-0.06	0	0	0	0
Net Cash Flow ⓘ	0.13	0.94	0.07	0.09	-1.38	-0.02	0.06	-0.75	0	0.01

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	1.82	1.75	0.85	0.88	-13.08	0.01	-0.12	0.42	6.09	0.83
ROCE (%)	2.7	2.33	1.17	1.11	-13.03	0	-0.08	0.42	7.57	0.43
Asset Turnover Ratio	0.4	0.35	0.37	0.35	0.19	0	0	0	0.11	0.04
PAT to CFO Conversion(x)	1.22	2.33	1.54	2.25	N/A	224	N/A	-10	0.79	3.3
Working Capital Days
Receivable Days	87	91	88	95	126	0	0	8,063	175	628
Inventory Days	97	111	91	92	106	0	0	0	2	4
Payable Days	53	76	71	87	69	0	0	0	152	1,837

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medi-Caps Ltd FAQs

The current trading price of Medi-Caps on 17-Apr-2026 16:59 is ₹29.85.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Medi-Caps stood at ₹37.22 Cr

The latest P/E ratio of Medi-Caps as of 16-Apr-2026 is 42.40.

The latest P/B ratio of Medi-Caps as of 16-Apr-2026 is 0.55.

The 52-week high of Medi-Caps is ₹46.99 and the 52-week low is ₹21.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medi-Caps is ₹2.65 ( Cr.) .

About Medi-Caps Ltd

Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Medi-Caps entered the highly competitive market with a team of dedicated professionals, duly supported by competent individuals in every aspect of operation.

Medi-Caps Groupâ€™s activities span manufacturing of Hard Gelatin Capsule Shells, Education, Industrial Packaging & related products, Finance, Real Estate and is a renowned name in central India.

Medi-Caps Institute of Technology and Management (MITM)
Medi-Caps Finance Limited
International Institute of Foreign Trade and Research (IIFTR)
Medpak India Limited
Trapti Investments (P) Limited
Mittal Enterprises
Akshit Finance (P) Limited

At Medi-Caps a philosophy of growth has been consistently upheld with good business practices. Clear focus, excellent infrastructure, a powerful quality policy and a well defined management information system have helped the company to achieve consistent growth. Today they offer printing features that are best in the industry. Medi-Caps has pioneered many advanced features in product development such as â€œPearlz Capsulesâ€ (Metallic Colored) as well as Python Printing & Li-Fill Caps.

Medi-Caps Limited continuously strives to offer its customers excellent product, technical advice, and a through professional service that makes their product tailor made for their customers both in India as well as abroad.

Their professional goals and corporate personality have blended so well that today Medi-Caps name has become synonymous with the best in the Industry.

Product range of the company includes:

The product product range comprises of six sizes ranging from 00,0el, 0, 1el, 1,2,3,4 in more than 1000 shades, the same is increasing as rapidly as Pharma Industry itself.

Empty Hard Gelatin Capsules
Halal Gelatin Capsules
Preservative Free Capsules
Sodium Lauryl Sulfate ( SLS ) free Capsules

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Medi-Caps Ltd (MEDICAPS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Medi-Caps Share Price